Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKesson
Citi
Mallinckrodt
Farmers Insurance
Accenture
Cantor Fitzgerald
Covington
Chubb
UBS

Generated: October 18, 2017

DrugPatentWatch Database Preview

MEFOXIN Drug Profile

« Back to Dashboard

What is the patent landscape for Mefoxin, and when can generic versions of Mefoxin launch?

Mefoxin is a drug marketed by Mylan Institutional and Merck and is included in four NDAs.

The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.

Summary for Tradename: MEFOXIN

US Patents:0
Applicants:2
NDAs:4
Bulk Api Vendors: see list33
Clinical Trials: see list1
Patent Applications: see list847
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEFOXIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
MEFOXIN
cefoxitin sodium
INJECTABLE;INJECTION050517-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION050581-004Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MEFOXIN
cefoxitin sodium
INJECTABLE;INJECTION062757-001Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MEFOXIN IN PLASTIC CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION063182-001Jan 25, 1993RXNoYes► Subscribe► Subscribe► Subscribe
Mylan Institutional
MEFOXIN
cefoxitin sodium
INJECTABLE;INJECTION050517-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MEFOXIN
cefoxitin sodium
INJECTABLE;INJECTION050517-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION050581-003Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MEFOXIN
cefoxitin sodium
INJECTABLE;INJECTION062757-002Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION050581-002Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Merck
MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION050581-001Sep 20, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chubb
Teva
Argus Health
McKinsey
Johnson and Johnson
Fish and Richardson
Covington
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot